Burden of COVID-19 during the omicron predominance in Brazil: a nationwide retrospective database study.

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has imposed significant burden on Brazil's health system. This study aimed to examine clinical characteristics, overall vaccine uptake, and to assess healthcare resource utilization (HCRU) and costs associated with acute COVID-19 in Brazil during the Omicron predominant period. METHODS: A nationwide retrospective study was conducted using various Brazilian databases including, COVID-19 related databases, public health systems, and other surveillance/demographic datasets. Individuals with positive COVID-19 test results between January 1 2022 and April 30 2022, during Omicron BA.1/BA.2 wave, were identified. Patients' demographics, vaccine uptake, HCRU and corresponding costs were described by age groups. RESULTS: A total of 8,160,715 (3.80%) COVID-19 cases were identified in the study cohort, ranging from 2.43% in <5 years to 62.05% in 19-49 years. The uptake of partial (Dose 1) or full immunization (Dose 2) was less than 0.1% in children aged <5 years, whereas in individuals ≥ 19 years, it exceeded 89.78% for Dose 1 and 84.07% for Dose 2. Overall booster vaccine uptake was 38.06%, which was significantly higher among individuals aged ≥ 65 years, surpassing 74.79%. Regardless of vaccination status, 87.2% cases were symptomatic, and 1.48% were hospitalized due to acute COVID-19 (<5 years: 2.33%, 5-11 years: 0.99%, 12-18 years: 0.32%, 19-49 years: 0.40%; 50-64 years: 1.50%, 65-74 years: 5.43%, and ≥ 75 years: 17.89%). Among the hospitalized patients (n = 120,450), 32.57% were admitted to ICU, of whom 31,283 (79.75%) individuals required mechanical ventilation (MV) support. The average cost per day in normal ward and ICU without MV in public/general hospital settings was $104.36 and $302.81, respectively. While average cost per day in normal ward and ICU with MV was $75.91 and $301.22 respectively. CONCLUSIONS: This study quantified the burden of COVID-19 in Brazil, suggesting substantial healthcare resources required to manage the COVID-19 pandemic.

Incidence, aetiology and serotype coverage for pneumococcal vaccines of community-acquired pneumonia in adults: a population-based prospective active surveillance study in Brazil.

OBJECTIVES: To determine the incidence, aetiology and pneumococcal serotype distribution of community-acquired pneumonia (CAP) in Brazilian adults during a 2-year period. DESIGN: Prospective population-based surveillance study. SETTING: Patients from two emergency hospitals in Brazil were consecutively included in this study. PARTICIPANTS: A total of 111 adults aged 50 years and older with radiographically-confirmed CAP requiring an emergency department visit were prospectively enrolled between January 2018 and January 2020. MAIN OUTCOME MEASURES: Incidence rates of CAP were calculated according to age and pathogen. Pathogens were identified by conventional microbiological methods. Additionally, a novel, Luminex-based serotype specific urinary antigen detection assay was used to detect serotypes included in pneumococcal vaccines. RESULTS: Mean age of participants was 64 years and 31% were aged ≥70 years. Aetiology was established in 61 (57%) patients; among identified cases, the most common pathogens were Streptococcus pneumoniae (42/61, 69%) and influenza (4/61, 7%). Among serotypes identified from the 42 cases of pneumococcal CAP, estimated coverage ranged by pneumococcal vaccine formulations from 47.6% (13-valent), 59.5% (20-valent, licenced in the USA only) and 71.4% (23-valent). In patients with CAP, 20-valent pneumococcal vaccine serotypes were identified 2.5 times more frequently than 10-valent pneumococcal vaccine serotypes (22.5% vs 9.0%). The incidence rate for CAP in adults aged ≥50 years was 20.1 per 10 000 person-years. In general, the incidence of CAP increased consistently with age, reaching 54.4 (95% CI 36.8 to -76.6) per 10 000 in adults 80 years or older. CONCLUSIONS: We observed a high burden of pneumococcal CAP among adults in Brazil. Despite the routine immunisation of children and high-risk adults against pneumococcal disease in the Brazilian national vaccination programme, a persistent burden of pneumococcal CAP caused by vaccine serotypes remains in this population.

Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis.

OBJECTIVES: The aim of this study was to evaluate the epidemiological profile of invasive meningococcal disease (IMD) in Brazil, the first Latin American country to introduce the group C meningococcal conjugate vaccine (included in the vaccination schedule in 2010). METHODS: A systematic review was conducted, covering the years 2005-2017, to identify epidemiological information on IMD and Neisseria meningitidis carriers in Brazil. Documents from the Brazilian Ministry of Health and two public databases were analyzed to determine annual incidence rates, absolute numbers of diagnosed cases, serogroups identified, the relative distribution of cases per serogroup, and the case fatality rate (CFR). RESULTS: Sixteen studies were selected. The incidence rate ranged from 0.88 to 5.3 cases per 100000 inhabitants per year. According to secondary data, the annual incidence of IMD in 2015 was highest in males <1year old (7.1/100000). The number of diagnosed cases declined significantly over the years. In the literature, IMD showed a CFR from 20.0% to 50.0%, and a higher CFR for serogroup W (17.8%). Secondary data showed an absolute reduction in meningitis-attributable deaths between 2007 and 2015; however, the CFR remained stable (11.1% in 2007 and 8.4% in 2015). In 2015, serogroup W showed the highest CFR (24.1%), followed by serogroups C (19.2%), B (17.7%), and Y (14.3%). CONCLUSIONS: Despite a reduction in cases, the CFR remained stable and similar in the different age groups, even for disease caused by different serogroups. The highest CFR was found to be associated with serogroup W.

Benign Inclusions in Lymph Nodes / Inclusiones Benignas en Linfonodos

Benign inclusions are foci of non-neoplastic ectopic tissue in lymph nodes. They are classified into three types: epithelial, nevomelanocytic and decidual. It is important to identify them for the differential diagnosis with lymph node metastases, particularly among patients who present proliferative benign lesions. In general, epithelial inclusions are presented inside lymph nodes as epithelial cysts or as numerous structures resembling ducts. The cells of these structures may originate from the cells of paramesonephricus ducts, salivary glands, breast tissue, thyroid follicles, squamous epithelium or mesothelium. Paramesonephricus -type inclusions are almost exclusively found in pelvic lymph nodes and, in appearance, they resemble the epithelium of the uterine tube. Inclusions of breast tissue are composed predominantly of ectopic mammary glands and ducts that present diverse morphological characteristics that still have obscure etiology. Thyroid-type inclusions are frequently found in cervical and axillary lymph nodes, and it is believed that, embryologically, they arise from the mixing of tissues from which lymph nodes and the thyroid gland originate. Mesothelial inclusions occur preferentially in the mediastinal lymph nodes of patients who are affected by pleural or pericardial effusions. Aggregates of melanocytic cells are generally found in the lymph node capsule. The explanation for this occurrence is uncertain, but it is believed to be a consequence of incorrect migration of neural crest cells, or because of "benign metastases" of nevi present in the skin. Studies on benign inclusions in lymph nodes take on importance through assisting in correctly diagnosing the presence of metastases.

Las inclusiones benignas son focos de tejido ectópico no neoplásico en los linfonodos. Ellos son clasificados en tres grupos: epitelial, nevomelanocítico y decidual. Es importante identificarlos para el diagnóstico diferencial con metástasis de linfonodos, particularmente en aquellos pacientes que presentan lesiones proliferativas benignas. En general, las inclusiones epiteliales se presentan dentro de los linfonodos como quistes epiteliales o como numerosas estructuras que parecen conductos. Las células de estas estructuras se pueden originar a partir de las células del conducto paramesonéfrico, glándulas salivales, tejido mamario, folículos tiroideos, epitelio escamoso o mesotelio. Las inclusiones tipo paramesonéfrico son exclusivamente encontradas en los linfonodos pélvicos y su apariencia recuerda el epitelio de la tuba uterina. Las inclusiones del tejido mamario están compuestas predominantemente de tejido mamario glandular ectópico y los ductos presentan diversas características morfológicas las que no tienen una clara etiología. Las inclusiones del tipo tiroideas son frecuentemente encontradas en los linfonodos cervicales y axilares y se cree que embriológicamene, se originan de una mezcla de tejidos de que origina linfonodos y tejido glandular tiroideo. Las inclusiones mesoteliales ocurren preferentemente en los linfonodos mediastínicos de pacientes que son afectados por dilataciones pleurales y pericárdicas. Los agregados de células melanocíticas son generalmente encontrados en la cápsula de los linfonodos. La explicación para este hecho es incierta, pero se cree que es una consecuencia incorrecta de la migración de células de la cresta neural o por metástasis benignas de nevos presentes en la piel. Los estudios de las inclusiones benignas en linfonodos toma importancia ya que a través de ellos se puede ayudar a un correcto diagnóstico de la presencia de metástasis.